ADVANCED LEIOMYOSARCOMA
Clinical trials for ADVANCED LEIOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED LEIOMYOSARCOMA trials appear
Sign up with your email to follow new studies for ADVANCED LEIOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First human trial launches for aggressive sarcoma drug duo
Disease control Recruiting nowThis early-stage study is testing the safety and best dose of a new drug, zanzalintinib, when combined with an existing cancer drug, eribulin. It is for adults with advanced liposarcoma or leiomyosarcoma, rare cancers of fat or muscle tissue, that have worsened after at least one…
Matched conditions: ADVANCED LEIOMYOSARCOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Apr 04, 2026 01:50 UTC
-
New Two-Drug attack tested for Tough-to-Treat sarcomas
Disease control Recruiting nowThis study is testing a new treatment approach for people with advanced soft tissue sarcomas, including leiomyosarcoma and dedifferentiated liposarcoma. It aims to find the safest dose and best schedule for combining the drug abemaciclib with chemotherapy (gemcitabine). The main …
Matched conditions: ADVANCED LEIOMYOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC